Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: A double-blind, randomized, placebo-controlled trial

BMC Urology

Volumn 8, Issue 1, 2008, Pages

  Lin, Alex Tong Long ^a   Sun, Mou Jong ^b   Tai, Hui Lung ^b   Chuang, Yao Chi ^c   Huang, Shih Tsung ^c   Wang, Nick ^d   Zhao, Yan Daniel ^d   Beyrer, Julie ^d   Wulster Radcliffe, Meghan ^d   Levine, Louise ^d   Chang, Curtis ^d   Viktrup, Lars ^d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; THIOPHENE DERIVATIVE;

ADULT; AGED; APPETITE; ARTICLE; ASTHENIA; CLINICAL TRIAL; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COUGHING; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FLATULENCE; HEART PALPITATION; HUMAN; HYPERHIDROSIS; HYPERTENSION; INSOMNIA; MAJOR CLINICAL STUDY; MORBIDITY; NAUSEA; OUTCOME ASSESSMENT; PHOBIA; PUBLICATION; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; STATISTICAL SIGNIFICANCE; STRESS INCONTINENCE; TAIWAN; THORAX PAIN; URINARY HESITANCY; VOMITING; XEROSTOMIA; MIDDLE AGED;

ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; TAIWAN; THIOPHENES; URINARY INCONTINENCE, STRESS;

EID: 40749140711     PISSN: 14712490     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-8-2     Document Type: Article

References (31)

1. Evaluation and Treatment of Urinary Incontinence, Pelvic Organ Prolapse, and Faecel Incontinence. P Abrams K Andersson LT Brubaker L Cardozo A Cottenden L Denis, 3rd International Consultation on Incontinence Plymouth: Health Publication Ltd, Abrams P, Cardozo L, Khoury S, Wein A, 2005 1589 1630
2. Pelvic floor muscle contraction during a cough and decreased vesical neck mobility. JM Miller D Perucchini LT Carchidi JO DeLancey J Ashton-Miller, Obstet Gynecol 2001 97 2 255 260 11165591 10.1016/S0029-7844(00)01132-7
3. Serotonergic modulation of spinal ascending activity and sacral reflex activity evoked by pelvic nerve stimulation in cats. MJ Espey H-J Du JW Downie, Brain Research 1998 798 1-2 101 108 10.1016/S0006-8993(98)00401-6 9666094
4. Unmasking of a neonatal somatovesical reflex in adult cats by the serotonin autoreceptor agonist 5-methoxy-N,N-dimethyltryptamine. KB Thor T Hisamitsu WC de Groat, Brain Research, Developmental Brain Research 1990 54 1 35 42 10.1016/0165-3806(90)90062-4
5. Spinal 5-HT2 receptor-mediated facilitation of pudendal nerve reflexes in the anaesthetized cat. H Danuser KB Thor, Br J Pharmacol 1996 118 1 150 154 8733588
6. Effects of clonidine on the lumbar sympathetic pathways to the large intestine and urinary bladder of the cat. J Krier KB Thor WC de Groat, Eur J Pharmacol 1979 59 1-2 47 53 10.1016/0014-2999(79)90023-2 510399
7. Effect of the alpha-adrenergic blocking agent thymoxamine on the neurogenic bladder and urethra. E Pedersen J Torring B Klemar, Acta Neurol Scand 1980 61 2 107 114 6446830
8. Experimental evidence for a central nervous system site of action in the effect of alpha-adrenergic blockers on the external urinary sphincter. J Gajewski JW Downie SA Awad, J Urol 1984 132 2 403 409 6145805
9. Alpha 2-adrenoceptors not imidazole receptors mediate depression of a sacral spinal reflex in the cat. JW Downie MJ Espey JB Gajewski, Eur J Pharmacol 1991 195 2 301 304 10.1016/0014-2999(91)90551-Z 1678710
10. Effect of 5-HT receptor and adrenoceptor antagonists on micturition in conscious cats. MJ Espey JW Downie A Fine, Eur J Pharmacol 1992 221 1 167 170 10.1016/0014-2999(92)90788-6 1360901
11. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat. KB Thor MA Katofiasc, J Pharmacol Exp Ther 1995 274 2 1014 1024 7636716
12. Definition of overactive bladder and epidemiology of urinary incontinence. C Hampel D Wienhold N Benken C Eggersmann JW Thuroff, Urology 1997 50 6A Suppl 4 14 10.1016/S0090-4295(97)00578-5 9426746
13. A Chinese anatomy: the pelvic supporting tissues of the Chinese and occidental female compared and contrasted. R Zacbarin, Aust N Z J Obstet Gynecol 1977 17 1
14. Prevalence and correlation of urinary incontinence and overactive bladder in Taiwanese women. GD Chen TL Lin SW Hu YC Chen LY Lin, Neurourol Urodyn 2003 22 2 109 117 10.1002/nau.10010 12579627
15. Urinary incontinence among the elderly people of Singapore. CC Ju LK Swan A Merriman TE Choon O Viegas, Age Ageing 1991 20 4 262 266 10.1093/ageing/20.4. 262 1927732
16. The prevalence of adult female urinary incontinence in Hong Kong Chinese. SS Ma, Int Urogynecol J Pelvic Floor Dysfunct 1997 8 6 327 331 10.1007/BF02765590 9609329
17. High prevalence of voiding symptoms in Taiwanese women. HJ Yu J Chen MK Lai KA Chan WC Chie, Br J Urol 1998 82 4 520 523 9806180
18. Duloxetine versus placebo in the treatment of stress urinary incontinence. PA Norton NR Zinner I Yalcin RC Bump, Am J Obstet Gynecol 2002 187 1 40 48 10.1067/mob.2002.124840 12114886
19. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. RR Dmochowski JR Miklos PA Norton NR Zinner I Yalcin RC Bump, J Urol 2003 170 4 Pt 1 1259 1263 10.1097/01.ju.0000080708.87092. cc 14501737
20. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence. P van Kerrebroeck P Abrams R Lange M Slack JJ Wyndaele I Yalcin RC Bump, BJOG 2004 111 3 249 257 10.1111/j.1471-0528.2004. 00067.x 14961887
21. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial. RJ Millard K Moore R Rencken I Yalcin RC Bump, BJU Int 2004 93 3 311 318 10.1111/j.1464-410X.2004.04607.x 14764128
22. Comparative efficacy of behavioral interventions in the management of female urinary incontinence. Continence Program for Women Research Group. JF Wyman JA Fantl DK McClish RC Bump, Am J Obstet Gynecol 1998 179 4 999 1007 10.1016/S0002-9378(98)70206-6 9790388
23. Bladder neck support prosthesis: a nonoperative treatment for stress or mixed urinary incontinence. A Kondo E Yokoyama K Koshiba J Fukui M Gotoh Y Yoshikawa T Yamada M Takei, J Urol 1997 157 3 824 827 10.1016/S0022-5347(01) 65055-9 9072577
24. Needle suspension procedures for female incontinence. DM Bodell GE Leach, Urol Clin North Am 2002 29 3 575 584 10.1016/S0094-0143(02)00073-3 12476521
25. Prospective analysis of patients treated with a distal urethral polypropylene sling for symptoms of stress urinary incontinence: surgical outcome and satisfaction determined by patient driven questionnaires. LV Rodriguez S Raz, J Urol 2003 170 3 857 863 10.1097/01.ju.0000083327.26420.99 12913716
26. Polypropylene sling for the treatment of stress urinary incontinence: intermediate-term results. N Itano C Berman LV Rodriguez S Raz, Journal of Urology 2003 169S 270
27. Quality of life of women with urinary incontinence: Further development of the incontinence quality of life instrument (I-QOL). DL Patrick ML Martin DM Bushnell I Yalcin TH Wagner DP Buesching, Urology 1999 53 1 71 76 10.1016/S0090-4295(98)00454-3 9886591
28. Validation of two global impression questionnaires for incontinence. I Yalcin RC Bump, American Journal of Obstetrics & Gynecology 2003 189 1 98 101 10.1067/mob.2003.379
29. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. AL Komaroff LR Fagioli TH Doolittle B Gandek MA Gleit RT Guerriero RJ Kornish 2nd NC Ware JE Ware Jr DW Bates, Am J Med 1996 101 3 281 290 10.1016/S0002-9343(96)00174-X 8873490
30. A review of the quality-of-life aspects of urinary urge incontinence. WR Lenderking JF Nackley RB Anderson MA Testa, Pharmacoeconomics 1996 9 1 11 23 10160084
31. Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence. NR Zinner, Expert Opin Investig Drugs 2003 12 9 1559 1566 10.1517/13543784.12.9.1559 12943499